Showing posts with label Lymphoedema. Show all posts
Showing posts with label Lymphoedema. Show all posts

Sunday, November 18, 2012

Possible Genetic Predisposition to Lymphedema after Breast Cancer

Possible Genetic Predisposition to Lymphedema after Breast Cancer

Lymphat Res Biol. 2012

Beth Newman, Ph.D.,1 Felicity Lose, Ph.D.,2 Mary-Anne Kedda, Ph.D.,1 Mathias Francois, Ph.D.,3 Kaltin Ferguson,2 Monika Janda, Ph.D.,1 Patsy Yates, Ph.D.,4 Amanda B. Spurdle, Ph.D.,2,* and Sandra C. Hayes, PhDcorresponding author1,*



Abstract

Background
Known risk factors for secondary lymphedema only partially explain who develops lymphedema following cancer, suggesting that inherited genetic susceptibility may influence risk. Moreover, identification of molecular signatures could facilitate lymphedema risk prediction prior to surgery or lead to effective drug therapies for prevention or treatment. Recent advances in the molecular biology underlying development of the lymphatic system and related congenital disorders implicate a number of potential candidate genes to explore in relation to secondary lymphedema.

Methods and Results

We undertook a nested case-control study, with participants who had developed lymphedema after surgical intervention within the first 18 months of their breast cancer diagnosis serving as cases (n=22) and those without lymphedema serving as controls (n=98), identified from a prospective, population-based, cohort study in Queensland, Australia. TagSNPs that covered all known genetic variation in the genes SOX18, VEGFC, VEGFD,VEGFR2, VEGFR3, RORC, FOXC2, LYVE1, ADM, and PROX1 were selected for genotyping. Multiple SNPs within three receptor genes, VEGFR2, VEGFR3, and RORC, were associated with lymphedema defined by statistical significance statistical significance  or extreme risk estimates

Conclusions

These provocative, albeit preliminary, findings regarding possible genetic predisposition to secondary lymphedema following breast cancer treatment warrant further attention for potential replication using larger datasets.

Saturday, November 03, 2012

π-Shaped lymphaticovenular anastomosis for head and neck lymphoedema: A preliminary study.


π-Shaped lymphaticovenular anastomosis for head and neck lymphoedema: A preliminary study.


Oct 2012

Source

Department of Plastic and Reconstructive Surgery, Nimes University Hospital, pl Pr Robert Debré, 30000 Nimes, France; Department of Plastic and Reconstructive Surgery, Breast Institute, 15, av Jean Jaurès, 90000 Belfort, France. Electronic address: bayestaray@yahoo.fr.

Abstract


BACKGROUND:

Head and neck lymphoedema secondary to jugular lymphadenectomy is a severe issue, without efficient solution. Successful treatment of lymphoedema of the upper and lower limbs has become possible with supermicrosurgical lymphaticovenular anastomosis. The technique based on two end-to-side anastomosis is named π-shaped lymphaticovenular anastomosis. We have evaluated this method for chronic head and neck lymphoedema.

METHODS:

From November 2010 to April 2011, four patients with a chronic head and neck lymphoedema were treated by π-shaped lymphaticovenular anastomosis. Three patients had a unilateral lymphoedema, and one patient had a bilaterallymphoedema. The mean age of the patients was 63.2 years (range, 46-77 years). The mean duration of the lymphoedemawas 2.6 years (range, 1-5). Every patient was operated under local anaesthesia through a face-lift skin incision. One π-shaped lymphaticovenular anastomosis was performed at each operative site.

RESULTS:

The average operative time to perform one π-shaped lymphaticovenular anastomosis was 1.9 h (range, 1.8-2.5). The calibre of lymphatic vessels used for lymphaticovenular anastomosis ranged from 0.3 to 0.7 mm (average, 0.5). A venous back-flow was found in seven lymphaticovenular anastomosis (70%). Three patients (75%) had a qualitative improvement of skin tissue and a significant circumferential reduction after surgery. The average circumferential differential reduction rate was 3.7% (range, 0.6-7.8) (p = 0.006). The average cross-sectional area differential reduction rate was 7.2% (range, 1.2-15.1) (p = 0.007). The average volume differential reduction rate was 6.9% (range, 2-14.8) (p = 0.05).

CONCLUSIONS:

The authors present a new option to treat head and neck lymphoedema. π-Shaped lymphaticovenular anastomosis is an effective method to reduce the severity of skin tissue fibrosis and lymphoedema volume. Further studies with larger groups of patients are required to confirm the outcome of this preliminary study. EBM Level = level 4.


see also:

Monday, August 27, 2012

Lymphedema treatment in palliative care: a case study.


Lymphedema treatment in palliative care: a case study.


Lymphoedema treatment in palliative care: a case study.


August 2012

Abstract


This article will focus on the evidence to support the treatment of a palliative patient who was diagnosed with cancer-related secondary lymphoedema. A case study approach has been adopted, which focuses on the anatomy and physiology oflymphoedema and how this is treated through an analysis of the treatment regimens. To establish the effectiveness of these treatment regimes, the use of objective and subjective tools will also be analysed to ascertain their importance within care. The findings of this case study and the supporting evidence indicate a positive correlation between the use of lymphoedematreatment methods in both limb volume reduction and quality-of-life outcomes. However, robust evidence is required to expand the importance of each treatment used in the area of lymphoedema management.

The Puzzle Lymphedema Book

The Puzzle Lymphedema Book

JUST A WEE REMINDER


Here's our new book on lymphedema. I also have a chapter with several articles.....

(including my own story). Pat


---------------------------------

The book is compiled so that people who have been touched by lymphedema can share their stories; their trials and tribulations, their sadness and disappointments, their strength and hopes. It is intended to encourage, educate and inspire patients and loved ones, who can often feel isolated and uninformed.
We hope to increase awareness and general knowledge of a condition that is often overlooked and misdiagnosed, yet which can have monumental physical and emotional impact on the lives that it affects.

Not every story has a happy ending, yet there is hope. By sharing these stories with one another, we can learn from the struggles and successes that others have
experienced, and can help each other to live well with lymphedema.

How do I get this book ???

This book will be available at:

15th State of Georgia Lymphedema Education And; Awareness Program 


15th State of Georgia Lymphedema Education & Awareness Conference
Saturday, October 27, 2012
Emory University Hospital Midtown, 550 Peachtree Street, Atlanta, GA 30308
7:30am-4:30pm 
Speakers include: Jane Armer, PhD, Richard Mistretta, DPM,
 Joseph Feldman, MD, and  David W. Chang, MD
  You may register online by clicking here.  To register by mail simply print the conference brochure and fill in the required information.  Print the Conference Brochure here.

Lighthouse Lymphedema Network Store

Book descrption

ALSO: We have a cookbook with recipes from members and friends:

LLN Favorite Recipes

Please mail your completed order form and donation to:

Lighthouse Lymphedema Network Book
10240 Crescent Ridge Drive
Roswell, GA 30076

Please send a donation of :
$19.95 per copy
Plus $5.00 per copy for Shipping Costs

Order Form

Name: Last First___________________________________________________

Mailing Address____________________________________________________

City State ZIP Code_________________________________________________

Home Telephone Number Cell Telephone Number________________________

Email Address_____________________________________________________

Number of Copies you would like to order______________________________

$_______________________________________________________________

Amount Enclosed________________________

Saturday, August 25, 2012

Children with Lymphedema Yahoo Group

Children with Lymphedema Yahoo Group

If you have a child with lymphedema, care for a child with lymphedema or am a family member of a child with lymphedema I wanted to be sure you knew about our very special children's group.

It is called Children with Lymphedema.

If you have ever felt alone, confused or overwhelmed with this, please do join us.

The camaraderie, information, encouragement and help is incredible within the group.  Members are from all over the world too.

See You There

Friday, February 24, 2012

Development and use of guideline-derived quality indicators for community lymphoedema.

Development and use of guideline-derived quality indicators for community lymphoedema.


Feb 2012


Abstract


Background  Treatment of lymphoedema is complex and needs specific skills. There are no standards for the evaluation of quality of care.


Objective 

Development and application of indicators for the measurement of quality of care in lymphoedema.


Methods 

In a three-step process including a national Delphi expert consensus, quality indicators were derived from national and international guidelines. In a cross-sectional study involving a large spectrum of care providers, the quality of lymphoedema care in the community was assessed by transforming the indicators to one unweighted quality index (QI).


Results 

A total of 12 quality indicators were identified and applied to n = 348 patients with lymphoedema and lipolymphoedema of any origin in the metropolitan area of Hamburg (90.8% female, mean age 57, SD 14.5 years). On average, 55% of the quality indicators were met, and 64.8% of the patients were satisfied with lymphoedema care.

There was a significant correlation between QI and satisfaction.

Conclusions 

The quality indicators and the QI are feasible and valid for the evaluation of quality of care. They can support optimizing lymphoedema care.

Wiley Online Library